Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction and permeability via the mitogen-activated protein kinase pathway in a rabbit model of atherosclerosis
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy August 2020 128 - Subject
- Language
- ISSN
- 0753-3322